Abstract Generative models are frequently used for de novo design in drug discovery projects to propose new molecules. However, the question of whether or not the generated molecules can be synthesized is not systematically taken into account during generation, even though being able to synthesize the generated molecules is a fundamental requirement for such methods to be useful in practice. Methods have been developed to estimate molecule “synthesizability”, but, so far, there is no consensus on whether or not a molecule is synthesizable. In this paper we introduce the Retro-Score (RScore), which computes a synthetic accessibility score of molecules by performing a full retrosynthetic analysis through our data-driven synthetic planning sof...
Designing compounds with desired properties is a key element of the drug discovery process. However,...
In recent years the scientific community has devoted much effort in the development of deep learning...
Abstract In recent years, the field of computational drug design has made significant strides in the...
© 2020 American Chemical Society. All rights reserved. The discovery of functional molecules is an e...
Computer aided synthesis planning (CASP) is part of a suite of artificial intelligence (AI) based to...
Abstract Modern computer-assisted synthesis planning tools provide strong support for this problem. ...
Machine learning (ML) and Artificial Intelligence (AI) have had a renaissance during the last few ye...
Deep generative models are able to suggest new organic molecules by generating strings, trees, and g...
Abstract Background A method to estimate ease of synthesis (synthetic accessibility) of drug-like mo...
While molecular discovery is critical for solving many scientific problems, the time and resource co...
With the increasing application of deep-learning-based generative models for de novo molecule design...
While a multitude of deep generative models have recently emerged there exists no best practice for ...
When designing new molecules with particular properties, it is not only important what to make but c...
Molecular design is a critical aspect of various scientific and industrial fields, where the propert...
© Deep Generative Models for Highly Structured Data, DGS@ICLR 2019 Workshop.All right reserved. Over...
Designing compounds with desired properties is a key element of the drug discovery process. However,...
In recent years the scientific community has devoted much effort in the development of deep learning...
Abstract In recent years, the field of computational drug design has made significant strides in the...
© 2020 American Chemical Society. All rights reserved. The discovery of functional molecules is an e...
Computer aided synthesis planning (CASP) is part of a suite of artificial intelligence (AI) based to...
Abstract Modern computer-assisted synthesis planning tools provide strong support for this problem. ...
Machine learning (ML) and Artificial Intelligence (AI) have had a renaissance during the last few ye...
Deep generative models are able to suggest new organic molecules by generating strings, trees, and g...
Abstract Background A method to estimate ease of synthesis (synthetic accessibility) of drug-like mo...
While molecular discovery is critical for solving many scientific problems, the time and resource co...
With the increasing application of deep-learning-based generative models for de novo molecule design...
While a multitude of deep generative models have recently emerged there exists no best practice for ...
When designing new molecules with particular properties, it is not only important what to make but c...
Molecular design is a critical aspect of various scientific and industrial fields, where the propert...
© Deep Generative Models for Highly Structured Data, DGS@ICLR 2019 Workshop.All right reserved. Over...
Designing compounds with desired properties is a key element of the drug discovery process. However,...
In recent years the scientific community has devoted much effort in the development of deep learning...
Abstract In recent years, the field of computational drug design has made significant strides in the...